BIOLOGICAL AGENTS IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS: A PHARMACOECONOMIC ANALYSIS

被引：0

作者：

Riveros, B. S. ^{[1
]}

Souza, T. T. ^{[1
]}

Godoy, R. R. ^{[1
]}

Garcia, M. ^{[1
]}

Goncalves, P. ^{[1
]}

Rotta, I ^{[1
]}

Otuki, M. F. ^{[1
]}

Pontarolo, R. ^{[1
]}

Correr, C. J. ^{[1
]}

机构：

[1] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil

来源：

VALUE IN HEALTH | 2013年 / 16卷 / 07期

关键词：

D O I：

10.1016/j.jval.2013.08.2276

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A726 / A726

页数：1

共 50 条

[1] EFFICIENCY OF BIOLOGIC AGENTS IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS
Blasco, A. J.
Lazaro, P.
Ferrandiz, C.
Garcia-Diez, A.
Liso, J.
[J]. ACTAS DERMO-SIFILIOGRAFICAS, 2009, 100 (09): : 792 - 803
[2] Moderate to severe psoriasis: from topical to biological treatment
Gardinal, I.
Ammoury, A.
Paul, C.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (11) : 1324 - 1326
[3] Comparison of Ustekinumab With Other Biological Agents for the Treatment of Moderate to Severe Plaque Psoriasis A Bayesian Network Meta-analysis
Lin, Vincent W.
Ringold, Sarah
Devine, Emily Beth
[J]. ARCHIVES OF DERMATOLOGY, 2012, 148 (12) : 1403 - 1410
[4] Pharmacoeconomic analysis of the treatment of moderate to severe inflammatory acne vulgaris
Gold, M
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB237 - AB237
[5] Tailored biological treatment for patients with moderate-to-severe psoriasis
Maurelli, Martina
Gisondi, Paolo
Girolomoni, Giampiero
[J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 37 - 43
[6] DRUG SURVIVAL RATES AND COST OF BIOLOGICAL AGENTS FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN THE BALEARIC ISLANDS (SPAIN)
Ventayol, P.
[J]. VALUE IN HEALTH, 2014, 17 (07) : A610 - A610
[7] EFFICIENCY (COST/EFFICACY) OF BIOLOGIC AGENTS IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS
Lazaro, P.
Blasco, A. J.
Ferrandiz, C.
Garcia, A.
Liso, J.
[J]. VALUE IN HEALTH, 2010, 13 (03) : A147 - A147
[8] Cost effectiveness of the use of infliximab compared to other biological agents (BA) in the systemic treatment of moderate to severe psoriasis
Fonseca, M.
Araujo, G.
[J]. VALUE IN HEALTH, 2007, 10 (03) : A99 - A99
[9] Moderate to severe psoriasis treatment challenges through the era of biological drugs
Vide, Julia
Magina, Sofia
[J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2017, 92 (05) : 667 - 673
[10] A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency
Staidle, Jonathan P.
Dabade, Tushar S.
Feldman, Steven R.
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (13) : 2041 - 2054

← 1 2 3 4 5 →